首页 | 本学科首页   官方微博 | 高级检索  
     

四川省越西县和昭觉县HIV抗病毒治疗停药患者耐药调查
引用本文:刘磊,肖林,汤杰,阿子罗林,谌茂刚,董敖渤,梁姝,邢辉,廖玲洁,冯毅,邵一鸣,阮玉华. 四川省越西县和昭觉县HIV抗病毒治疗停药患者耐药调查[J]. 中国热带医学, 2020, 20(5): 402-408. DOI: 10.13604/j.cnki.46-1064/r.2020.05.02
作者姓名:刘磊  肖林  汤杰  阿子罗林  谌茂刚  董敖渤  梁姝  邢辉  廖玲洁  冯毅  邵一鸣  阮玉华
作者单位:1.中国疾病预防控制中心性病艾滋病预防控制中心,北京 102206;2. 凉山彝族自治州疾病预防控制中心,四川 西昌 615000;3. 越西县疾病预防控制中心,四川 越西616650;4. 昭觉县疾病预防控制中心,四川 昭觉 616150;5.四川省疾病预防控制中心,四川 成都 610000
基金项目:国家自然科学基金(No.11471336,11971479);国家科技重大专项(No.2017ZX10201101);四川凉山防艾攻坚工程
摘    要:目的了解四川凉山州HIV抗病毒治疗停药患者的耐药情况。方法在四川省凉山州选择抗病毒治疗人数较多的越西县和昭觉县两个治疗点,对其2018年HIV抗病毒治疗停药患者按照抗病毒治疗号顺序进行横断面调查,收集调查对象社会人口学、高危行为以及抗病毒治疗情况等数据;采集全血分离血浆检测病毒载量,提取核酸和pol基因区扩增测序进行耐药检测。结果调查273例患者,54.7%(140/273)患者的病毒载量≥1000拷贝/mL;成功获得206份序列进行耐药分析,16.0%(33/206)患者检出耐药。病毒载量≥1000拷贝/mL的比例随着停药时间的延长而增大,而耐药的比例随着停药时间的延长而减小。昭觉县的耐药率高于越西县(aOR=2.97,95%CI=1.17~7.54,P=0.022);未婚的患者耐药率比在婚或同居的患者高(aOR=2.58,95%CI=1.27~7.40,P=0.042)。停药时间>24个月患者的耐药率比停药时间1~<24个月低(aOR=0.32,95%CI=0.14~0.76,P=0.001)。近一年内发生无保护性行为的比例为72.2%。结论HIV抗病毒治疗停药患者耐药和无保护性行为比例均高,需对该人群加强宣传教育,减少HIV毒株尤其是耐药株的传播。

关 键 词:艾滋病病毒  抗病毒治疗  停药  病毒载量  耐药  高危行为
收稿时间:2020-01-19

Drug resistance in HIV/AIDS patients who stopped ART in Yuexi and Zhaojue of Liangshan,Sichuan
LIU Lei,XIAO Lin,TANG Jie,AZI Luolin,CHEN Maogang,DONG aobo,LIANG Shu,XING Hui,LIAO Lingjie,FENGYi,SHAO Yiming,RUAN Yuhua. Drug resistance in HIV/AIDS patients who stopped ART in Yuexi and Zhaojue of Liangshan,Sichuan[J]. China Tropical Medicine, 2020, 20(5): 402-408. DOI: 10.13604/j.cnki.46-1064/r.2020.05.02
Authors:LIU Lei  XIAO Lin  TANG Jie  AZI Luolin  CHEN Maogang  DONG aobo  LIANG Shu  XING Hui  LIAO Lingjie  FENGYi  SHAO Yiming  RUAN Yuhua
Affiliation:1. National Center for AIDS/STD Control and prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China;2. Liangshan Center of Disease Prevention and Control,Xichang,Sichuan 615000, China;3. Yuexi Center of Disease Prevention and Control, Yuexi,Sichuan 616650, China;4. Zhaojue Center of Disease Prevention and Control, Zhaojue,Sichuan 616150, China;5. Sichuan Provincial Center of Disease Prevention and Control, Chengdu,Sichuan 610000, China
Abstract:Objective To investigate the prevalence of drug resistance in HIV/AIDS patients who had stopped antiretroviral therapy in Liangshan, 2018. Methods A cross-sectional survey was conducted among the HIV/AIDS patients who had stopped antiretroviral therapy in Yuexi and Zhaojue of Liangshan, 2018.Data on social demography, high-risk behaviors and antiviral treatment were collected.The blood samples were collected and HIV-1 viral load was detected. The samples and polgene were amplified and sequenced for drug resistance testing. Results Of the 273 HIV/AIDS patients who had stopped ART, 140(54.7%) cases viral loads were higher than 1 000 copies/mL. Among 206 samples which were successfully amplified and sequenced, 33(16.0%) individuals showed resistance to NRTIs, NNRTIs and PIs. With the increase of stopping time, the proportion of viral load ≥1 000 copies/mL increased,and the drug resistance rate decreased, separately. The drug resistance rate of Zhaojue county was higher than that of Yuexi county (aOR = 2.97,95%CI=1.17- 7.54, P= 0.022). The drug resistance rate of unmarried patients was higher than that of married or cohabiting patients (aOR=2.58,95%CI=1.27-7.41, P=0.042). The drug resistance rate of patients stopped ART >24 months was lower than that of 1-<24 months (aOR=0.32, 95%CI=0.14-0.76, P=0.001). The proportion of high risk sexual behavior in the last year was 72.2%. Conclusion HIV/AIDS patients who had stopped antiretroviral therapy in our research have high drug resistance rate and high risk sexual behavior proportion. We suggest that the management and interventions of those people should be strengthen to control the transmission of HIV, especially HIV resistant strain.
Keywords:HIV  antiretroviral therapy  stopped ART  viral load  drug resistance  risk behaviors  
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国热带医学》浏览原始摘要信息
点击此处可从《中国热带医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号